Cargando…

Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network

BACKGROUND: Pancreatic cancer is an insidious and heterogeneous malignancy with poor prognosis that is often locally unresectable. Therefore, determining the underlying mechanisms and effective prognostic indicators of pancreatic cancer may help optimize clinical management. This study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yuanxu, Lu, Jiongdi, Mei, Wentong, Jia, Yuchen, Bian, Chunjing, Ding, Yixuan, Guo, Yulin, Cao, Feng, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745361/
https://www.ncbi.nlm.nih.gov/pubmed/36523322
http://dx.doi.org/10.21037/tcr-22-709
_version_ 1784849135862546432
author Qu, Yuanxu
Lu, Jiongdi
Mei, Wentong
Jia, Yuchen
Bian, Chunjing
Ding, Yixuan
Guo, Yulin
Cao, Feng
Li, Fei
author_facet Qu, Yuanxu
Lu, Jiongdi
Mei, Wentong
Jia, Yuchen
Bian, Chunjing
Ding, Yixuan
Guo, Yulin
Cao, Feng
Li, Fei
author_sort Qu, Yuanxu
collection PubMed
description BACKGROUND: Pancreatic cancer is an insidious and heterogeneous malignancy with poor prognosis that is often locally unresectable. Therefore, determining the underlying mechanisms and effective prognostic indicators of pancreatic cancer may help optimize clinical management. This study was conducted to develop a prognostic model for pancreatic cancer based on a competing endogenous RNA (ceRNA) network. METHODS: We obtained transcriptomic data and corresponding clinicopathological information of pancreatic cancer samples from The Cancer Genome Atlas (TCGA) database (training set). Based on the ceRNA interaction network, we screened candidate genes to build prediction models. Univariate Cox regression analysis was performed to screen for genes associated with prognosis, and least absolute shrinkage and selection operator (LASSO) regression analysis was conducted to construct a predictive model. A receiver operating characteristic (ROC) curve was drawn, and the C-index was calculated to evaluate the accuracy of the prediction model. Furthermore, we downloaded transcriptomic data and related clinical information of pancreatic cancer samples from the Gene Expression Omnibus database (validation set) to evaluate the robustness of our prediction model. RESULTS: Eight genes (ANLN, FHDC1, LY6D, SMAD6, ACKR4, RAB27B, AUNIP, and GPRIN3) were used to construct the prediction model, which was confirmed as an independent predictor for evaluating the prognosis of patients with pancreatic cancer through univariate and multivariate Cox regression analysis. By plotting the decision curve, we found that the risk score model is an independent predictor has the greatest impact on survival compared to pathological stage and targeted molecular therapy. CONCLUSIONS: An eight-gene prediction model was constructed for effectively and independently predicting the prognosis of patients with pancreatic cancer. These eight genes identified show potential as diagnostic and therapeutic targets.
format Online
Article
Text
id pubmed-9745361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-97453612022-12-14 Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network Qu, Yuanxu Lu, Jiongdi Mei, Wentong Jia, Yuchen Bian, Chunjing Ding, Yixuan Guo, Yulin Cao, Feng Li, Fei Transl Cancer Res Original Article BACKGROUND: Pancreatic cancer is an insidious and heterogeneous malignancy with poor prognosis that is often locally unresectable. Therefore, determining the underlying mechanisms and effective prognostic indicators of pancreatic cancer may help optimize clinical management. This study was conducted to develop a prognostic model for pancreatic cancer based on a competing endogenous RNA (ceRNA) network. METHODS: We obtained transcriptomic data and corresponding clinicopathological information of pancreatic cancer samples from The Cancer Genome Atlas (TCGA) database (training set). Based on the ceRNA interaction network, we screened candidate genes to build prediction models. Univariate Cox regression analysis was performed to screen for genes associated with prognosis, and least absolute shrinkage and selection operator (LASSO) regression analysis was conducted to construct a predictive model. A receiver operating characteristic (ROC) curve was drawn, and the C-index was calculated to evaluate the accuracy of the prediction model. Furthermore, we downloaded transcriptomic data and related clinical information of pancreatic cancer samples from the Gene Expression Omnibus database (validation set) to evaluate the robustness of our prediction model. RESULTS: Eight genes (ANLN, FHDC1, LY6D, SMAD6, ACKR4, RAB27B, AUNIP, and GPRIN3) were used to construct the prediction model, which was confirmed as an independent predictor for evaluating the prognosis of patients with pancreatic cancer through univariate and multivariate Cox regression analysis. By plotting the decision curve, we found that the risk score model is an independent predictor has the greatest impact on survival compared to pathological stage and targeted molecular therapy. CONCLUSIONS: An eight-gene prediction model was constructed for effectively and independently predicting the prognosis of patients with pancreatic cancer. These eight genes identified show potential as diagnostic and therapeutic targets. AME Publishing Company 2022-11 /pmc/articles/PMC9745361/ /pubmed/36523322 http://dx.doi.org/10.21037/tcr-22-709 Text en 2022 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Qu, Yuanxu
Lu, Jiongdi
Mei, Wentong
Jia, Yuchen
Bian, Chunjing
Ding, Yixuan
Guo, Yulin
Cao, Feng
Li, Fei
Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
title Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
title_full Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
title_fullStr Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
title_full_unstemmed Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
title_short Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
title_sort prognostic biomarkers of pancreatic cancer identified based on a competing endogenous rna regulatory network
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745361/
https://www.ncbi.nlm.nih.gov/pubmed/36523322
http://dx.doi.org/10.21037/tcr-22-709
work_keys_str_mv AT quyuanxu prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT lujiongdi prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT meiwentong prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT jiayuchen prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT bianchunjing prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT dingyixuan prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT guoyulin prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT caofeng prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork
AT lifei prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork